Joon Lee
Stock Analyst at Truist Securities
(4.71)
# 149
Out of 4,905 analysts
121
Total ratings
57.41%
Success rate
42.34%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Joon Lee
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SAGE Sage Therapeutics | Maintains: Hold | $8 → $9 | $9.12 | -1.26% | 12 | Jun 17, 2025 | |
| PTCT PTC Therapeutics | Initiates: Buy | $80 | $47.63 | +67.96% | 1 | Jun 17, 2025 | |
| VKTX Viking Therapeutics | Reiterates: Buy | $95 → $75 | $32.01 | +134.30% | 8 | Apr 28, 2025 | |
| ARVN Arvinas | Maintains: Buy | $65 → $21 | $7.35 | +185.71% | 6 | Apr 9, 2025 | |
| CORT Corcept Therapeutics | Maintains: Buy | $76 → $150 | $70.86 | +111.69% | 8 | Mar 31, 2025 | |
| NTLA Intellia Therapeutics | Maintains: Buy | $90 → $50 | $12.06 | +314.59% | 4 | Mar 4, 2025 | |
| PRAX Praxis Precision Medicines | Maintains: Buy | $175 → $85 | $53.85 | +57.85% | 5 | Mar 3, 2025 | |
| AXSM Axsome Therapeutics | Maintains: Buy | $190 → $200 | $111.70 | +79.05% | 5 | Feb 19, 2025 | |
| CRSP CRISPR Therapeutics AG | Maintains: Buy | $100 → $120 | $65.13 | +84.25% | 5 | Feb 12, 2025 | |
| VRTX Vertex Pharmaceuticals | Maintains: Buy | $460 → $520 | $459.81 | +13.09% | 3 | Feb 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $18 | $3.21 | +460.75% | 1 | Jan 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $660 → $700 | $564.59 | +23.98% | 12 | Jan 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $44 → $57 | $104.90 | -45.66% | 6 | Jan 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $16 | $6.39 | +150.39% | 1 | Jan 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $17 → $36 | $8.34 | +331.65% | 3 | Nov 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $30 → $36 | $21.03 | +71.18% | 7 | Nov 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $12 → $8 | $2.76 | +189.86% | 7 | Nov 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $12 → $17 | $10.86 | +56.54% | 7 | Oct 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $118 → $90 | $57.29 | +57.10% | 2 | Sep 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $60 → $40 | $2.77 | +1,344.04% | 6 | Aug 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $200 | $112.87 | +77.20% | 2 | Mar 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $6 → $5 | $2.57 | +94.55% | 7 | Sep 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $18 | $3.24 | +455.56% | 1 | May 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $280 | $3.54 | +7,809.60% | 1 | Oct 20, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $27 → $34 | $25.92 | +31.17% | 1 | Mar 16, 2021 |
Sage Therapeutics
Jun 17, 2025
Maintains: Hold
Price Target: $8 → $9
Current: $9.12
Upside: -1.26%
PTC Therapeutics
Jun 17, 2025
Initiates: Buy
Price Target: $80
Current: $47.63
Upside: +67.96%
Viking Therapeutics
Apr 28, 2025
Reiterates: Buy
Price Target: $95 → $75
Current: $32.01
Upside: +134.30%
Arvinas
Apr 9, 2025
Maintains: Buy
Price Target: $65 → $21
Current: $7.35
Upside: +185.71%
Corcept Therapeutics
Mar 31, 2025
Maintains: Buy
Price Target: $76 → $150
Current: $70.86
Upside: +111.69%
Intellia Therapeutics
Mar 4, 2025
Maintains: Buy
Price Target: $90 → $50
Current: $12.06
Upside: +314.59%
Praxis Precision Medicines
Mar 3, 2025
Maintains: Buy
Price Target: $175 → $85
Current: $53.85
Upside: +57.85%
Axsome Therapeutics
Feb 19, 2025
Maintains: Buy
Price Target: $190 → $200
Current: $111.70
Upside: +79.05%
CRISPR Therapeutics AG
Feb 12, 2025
Maintains: Buy
Price Target: $100 → $120
Current: $65.13
Upside: +84.25%
Vertex Pharmaceuticals
Feb 11, 2025
Maintains: Buy
Price Target: $460 → $520
Current: $459.81
Upside: +13.09%
Jan 29, 2025
Initiates: Buy
Price Target: $18
Current: $3.21
Upside: +460.75%
Jan 14, 2025
Reiterates: Buy
Price Target: $660 → $700
Current: $564.59
Upside: +23.98%
Jan 8, 2025
Reiterates: Buy
Price Target: $44 → $57
Current: $104.90
Upside: -45.66%
Jan 8, 2025
Initiates: Buy
Price Target: $16
Current: $6.39
Upside: +150.39%
Nov 12, 2024
Maintains: Buy
Price Target: $17 → $36
Current: $8.34
Upside: +331.65%
Nov 11, 2024
Maintains: Buy
Price Target: $30 → $36
Current: $21.03
Upside: +71.18%
Nov 5, 2024
Maintains: Buy
Price Target: $12 → $8
Current: $2.76
Upside: +189.86%
Oct 22, 2024
Maintains: Buy
Price Target: $12 → $17
Current: $10.86
Upside: +56.54%
Sep 17, 2024
Maintains: Buy
Price Target: $118 → $90
Current: $57.29
Upside: +57.10%
Aug 14, 2024
Maintains: Buy
Price Target: $60 → $40
Current: $2.77
Upside: +1,344.04%
Mar 20, 2024
Reiterates: Buy
Price Target: $200
Current: $112.87
Upside: +77.20%
Sep 20, 2023
Maintains: Buy
Price Target: $6 → $5
Current: $2.57
Upside: +94.55%
May 10, 2023
Initiates: Buy
Price Target: $18
Current: $3.24
Upside: +455.56%
Oct 20, 2021
Initiates: Buy
Price Target: $280
Current: $3.54
Upside: +7,809.60%
Mar 16, 2021
Upgrades: Buy
Price Target: $27 → $34
Current: $25.92
Upside: +31.17%